Cargando…

ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation

SIMPLE SUMMARY: ASCT2 and LAT1 are amino acid transporters whose impact in cancer has been explored throughout the years. They have been associated with most currently accepted hallmarks of cancer, thus the aim of this review is to report the impact of these transporters in this disease, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopes, Catarina, Pereira, Carina, Medeiros, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828050/ https://www.ncbi.nlm.nih.gov/pubmed/33429909 http://dx.doi.org/10.3390/cancers13020203

Ejemplares similares

LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
por: Dias, Francisca, et al.
Publicado: (2021)

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
por: Toyoda, M, et al.
Publicado: (2014)

Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth
por: Bothwell, Paige J., et al.
Publicado: (2018)

Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
por: Polet, Florence, et al.
Publicado: (2016)

SLC transporters ASCT2, B(0)AT1‐like, y(+)LAT1, and LAT4‐like associate with methionine electrogenic and radio‐isotope flux kinetics in rainbow trout intestine
por: To, Van P. T. H., et al.
Publicado: (2019)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach
por: Rajasinghe, Lichchavi Dhananjaya, et al.
Publicado: (2019)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Translating the molecular hallmarks of colorectal cancer to patient therapies: an interview with Owen Sansom
Publicado: (2014)

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
por: Song, Yang, et al.
Publicado: (2023)

ASCT2 is the primary serine transporter in cancer cells
por: Conger, Kelly O., et al.
Publicado: (2023)

Revisiting Retinal Degeneration Hallmarks: Insights from Molecular Markers and Therapy Perspectives
por: Rosa, João Gabriel Santos, et al.
Publicado: (2023)

The Treatment of Multiple Myeloma Patients Not Eligible for Asct
por: Richardson, Paul, et al.
Publicado: (2010)

Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
por: Toda, Kosuke, et al.
Publicado: (2017)

Hallmarks of cancer and hallmarks of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Genetic Variations in Prostaglandin E(2) Pathway Identified as Susceptibility Biomarkers for Gastric Cancer in an Intermediate Risk European Country
por: Lopes, Catarina, et al.
Publicado: (2021)

Hallmarks of Aging: An Autophagic Perspective
por: Barbosa, María Carolina, et al.
Publicado: (2019)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
por: Sun, Hong-Wei, et al.
Publicado: (2016)

Epigenetic Activation of ASCT2 in the Hippocampus Contributes to Depression-Like Behavior by Regulating D-Serine in Mice
por: Wang, Jiesi, et al.
Publicado: (2017)

Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer
por: Ma, Li-cong, et al.
Publicado: (2020)

The Molecular Mechanism of Polyphenols in the Regulation of Ageing Hallmarks
por: Pereira, Quélita Cristina, et al.
Publicado: (2023)

An Update to Hallmarks of Cancer
por: Ravi, Swapna, et al.
Publicado: (2022)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance
por: Rotoli, Bianca Maria, et al.
Publicado: (2019)

The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
por: De Palma, Fatima Domenica Elisa, et al.
Publicado: (2019)

Cysteine 467 of the ASCT2 Amino Acid Transporter Is a Molecular Determinant of the Antiport Mechanism
por: Scalise, Mariafrancesca, et al.
Publicado: (2022)

Hallmarks of cancer: The insulin-like growth factors perspective
por: Werner, Haim, et al.
Publicado: (2022)

LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state
por: Furth, Noa, et al.
Publicado: (2018)

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
por: Najafi, Maryam, et al.
Publicado: (2016)

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
por: Dai, Xiaofeng, et al.
Publicado: (2016)

Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives
por: Choi, Yoon Young, et al.
Publicado: (2016)

Prostaglandin E(2) Pathway Is Dysregulated in Gastric Adenocarcinoma in a Caucasian Population
por: Lopes, Catarina, et al.
Publicado: (2020)

Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer()
por: Vaklavas, Christos, et al.
Publicado: (2020)

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019)

Cell Morphogenesis Proteins Are Translationally Controlled through UTRs by the Ndr/LATS Target Ssd1
por: Wanless, Antony G., et al.
Publicado: (2014)

Molecular chess? Hallmarks of anti-cancer drug resistance
por: Cree, Ian A., et al.
Publicado: (2017)

Molecular principles of metastasis: a hallmark of cancer revisited
por: Fares, Jawad, et al.
Publicado: (2020)

The impact of insomnia on frailty and the hallmarks of aging
por: Carvalhas-Almeida, Catarina, et al.
Publicado: (2022)

miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3
por: Nobre, Rui Jorge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9aucsivooi8q36i52d6raao06m